Covariate | Stratification | N | % |
---|---|---|---|
Tumor Location | Superior Half | 189 | 75.3 |
Inferior Half | 62 | 24.7 | |
Pathology | DCIS | 28 | 11.2 |
Ductal | 202 | 80.5 | |
Lobular | 10 | 4.0 | |
Mixed | 5 | 2.0 | |
Other | 6 | 2.4 | |
Grading | G1 | 34 | 13.5 |
G2 | 136 | 54.2 | |
G3 | 67 | 26.7 | |
Gx | 14 | 5.6 | |
Estrogen Receptors | Negative | 39 | 15.5 |
Positive | 210 | 83.7 | |
Unknown | 2 | 0.8 | |
Progesterone Receptors | Negative | 59 | 23.5 |
Positive | 190 | 75.7 | |
Unknown | 2 | 0.8 | |
Menopausal Status | Premenopausal | 70 | 27.9 |
Postmenopausal | 181 | 72.1 | |
Axilla staging | 143 | 57.0 | |
AND | 88 | 35.0 | |
None | 20 | 8.0 | |
pT Stage | DCIS | 28 | 11.2 |
pT1mic | 4 | 1.6 | |
pT1a | 15 | 6.0 | |
pT1b | 37 | 14.7 | |
pT1c | 109 | 43.4 | |
pT2 | 58 | 23.1 | |
pN Stage | pN0 | 180 | 71.7 |
pNmic | 7 | 2.8 | |
pN1a | 44 | 17.5 | |
pNx | 20 | 8.0 | |
Adjuvant tmt | None | 20 | 8.0 |
Hormones | 132 | 52.6 | |
Chemotherapy | 31 | 12.4 | |
Chemotherapy + Hormones | 68 | 27.1 |